chr11-1556867-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004420.3(DUSP8):​c.1529C>T​(p.Pro510Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000154 in 975,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

DUSP8
NM_004420.3 missense

Scores

2
1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.822
Variant links:
Genes affected
DUSP8 (HGNC:3074): (dual specificity phosphatase 8) The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which is associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates SAPK/JNK and p38, is expressed predominantly in the adult brain, heart, and skeletal muscle, is localized in the cytoplasm, and is induced by nerve growth factor and insulin. An intronless pseudogene for DUSP8 is present on chromosome 10q11.2. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10095081).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DUSP8NM_004420.3 linkuse as main transcriptc.1529C>T p.Pro510Leu missense_variant 7/7 ENST00000397374.8 NP_004411.2 Q13202
DUSP8XM_011519932.3 linkuse as main transcriptc.1529C>T p.Pro510Leu missense_variant 7/7 XP_011518234.1 Q13202
DUSP8XM_011519933.3 linkuse as main transcriptc.1529C>T p.Pro510Leu missense_variant 7/7 XP_011518235.1 Q13202
DUSP8XM_047426513.1 linkuse as main transcriptc.1487C>T p.Pro496Leu missense_variant 7/7 XP_047282469.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DUSP8ENST00000397374.8 linkuse as main transcriptc.1529C>T p.Pro510Leu missense_variant 7/71 NM_004420.3 ENSP00000380530.3 Q13202
DUSP8ENST00000331588.4 linkuse as main transcriptc.1529C>T p.Pro510Leu missense_variant 6/61 ENSP00000329539.4 Q13202

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.0000154
AC:
15
AN:
975226
Hom.:
0
Cov.:
33
AF XY:
0.00000872
AC XY:
4
AN XY:
458462
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000625
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000152
Gnomad4 OTH exome
AF:
0.0000278
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 19, 2024The c.1529C>T (p.P510L) alteration is located in exon 7 (coding exon 6) of the DUSP8 gene. This alteration results from a C to T substitution at nucleotide position 1529, causing the proline (P) at amino acid position 510 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.054
T;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.084
N
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.10
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.92
L;L
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.064
Sift
Benign
0.17
T;T
Sift4G
Benign
0.25
T;T
Polyphen
0.0010
B;B
Vest4
0.082
MutPred
0.23
Loss of glycosylation at P510 (P = 0.0277);Loss of glycosylation at P510 (P = 0.0277);
MVP
0.11
MPC
0.98
ClinPred
0.091
T
GERP RS
2.8
Varity_R
0.065
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1848634334; hg19: chr11-1578097; API